Literature DB >> 8436091

Fatty acid composition of serum phosphatidylcholine in healthy subjects consuming varying amounts of fish.

B G Svensson1, B Akesson, A Nilsson, S Skerfving.   

Abstract

Fatty acid composition of serum phosphatidylcholine was studied in subjects living in the same area and selected for high consumption of fat fish, high consumption of lean fish, moderate or no consumption of fish. The proportion of eicosapentaenoic acid (20:5) in serum phosphatidylcholine was fourfold higher, and that of docosahexaenoic acid (22:6) twofold higher among high consumers of fish compared to non-consumers, and these proportions were also higher in fat fish consumers than in high consumers of lean fish, and in moderate consumers compared to non-consumers. In the whole group the intake of fat fish was correlated to the proportions of 20:5, 22:6 and total n-3 fatty acids in serum phosphatidylcholine. The estimated intake of total n-3 fatty acids from fish was highly correlated to the proportions of these fatty acids in serum phosphatidylcholine (r = 0.87). Plasma triglyceride concentration was lower among high fat fish consumers than in other groups, but no differences between groups were observed for concentration of cholesterol, LDL cholesterol, and HDL cholesterol. It is concluded that subjects who consume high amounts of fat fish in their normal diet attain approximately the same proportions of n-3 fatty acids in serum phosphatidylcholine as reported for subjects taking fish oil supplements, and that fatty acid composition of serum lipids can be used as a marker of intake of fat fish.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436091

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  7 in total

1.  Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.

Authors:  H M Vidgren; J J Agren; U Schwab; T Rissanen; O Hänninen; M I Uusitupa
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Habitual fish intake is associated with decreased LDL susceptibility to ex vivo oxidation.

Authors:  Gordoa Juan Carlos de Ruiz; Ana del Cerro; Labastida Eva de Fernandez; Pilar Amiano; Miren Dorronsoro
Journal:  Lipids       Date:  2002-04       Impact factor: 1.880

3.  Parameters of immunological competence in subjects with high consumption of fish contaminated with persistent organochlorine compounds.

Authors:  B G Svensson; T Hallberg; A Nilsson; A Schütz; L Hagmar
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

4.  Does dietary arsenic and mercury affect cutaneous bleeding time and blood lipids in humans?

Authors:  H M Meltzer; H H Mundal; J Alexander; K Bibow; T A Ydersbond
Journal:  Biol Trace Elem Res       Date:  1994 Oct-Nov       Impact factor: 3.738

5.  Evaluation of the impact of genetic polymorphisms in glutathione-related genes on the association between methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction: a case-control study.

Authors:  Karin S Engström; Maria Wennberg; Ulf Strömberg; Ingvar A Bergdahl; Göran Hallmans; Jan-Håkan Jansson; Thomas Lundh; Margareta Norberg; Gerda Rentschler; Bengt Vessby; Staffan Skerfving; Karin Broberg
Journal:  Environ Health       Date:  2011-04-19       Impact factor: 5.984

6.  PCDDs, PCDFs, and PCBs in human blood in relation to consumption of crabs from a contaminated Fjord area in Norway.

Authors:  H R Johansen; J Alexander; O J Rossland; S Planting; M Løvik; P I Gaarder; W Gdynia; K S Bjerve; G Becher
Journal:  Environ Health Perspect       Date:  1996-07       Impact factor: 9.031

7.  Genetic variation in glutathione-related genes and body burden of methylmercury.

Authors:  Karin Schläwicke Engström; Ulf Strömberg; Thomas Lundh; Ingegerd Johansson; Bengt Vessby; Göran Hallmans; Staffan Skerfving; Karin Broberg
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.